Identifying patients with benign prostatic hyperplasia through a diagnosis of, or treatment for, erectile dysfunction

References

• Berry S, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474–9
   PubMed Web of Science ®Google Scholar
• Mariappan P, Chong WL. Prevalence and correlations of lower urinary tract symptoms, erectile dysfunction and incontinence in men from a multiethnic Asian population: results of a regional population-based survey and comparison with industrialized nations. BJU Int 2006;98:1264–8
   PubMed Web of Science ®Google Scholar
• Liu CC, Huang SP, Li WM, et al. Are lower urinary tract symptoms associated with erectile dysfunction in aging males of Taiwan? Urol Int 2006;77:251–4
   PubMed Web of Science ®Google Scholar
• Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003;44:637–49
   PubMed Web of Science ®Google Scholar
• Stroberg P, Boman H, Gellerstedt M, et al. Relationships between lower urinary tract symptoms, the bother they induce and erectile dysfunction. Scand J Urol Nephrol 2006;40:307–12
   PubMed Web of Science ®Google Scholar
• Aslan G, Cavus E, Karas H, et al. Association between lower urinary tract symptoms and erectile dysfunction. Arch Androl 2006;52:155–62
   PubMed Web of Science ®Google Scholar
• Paick SH, Meehan A, Lee M, et al. The relationship among lower urinary tract symptoms, prostate specific antigen and erectile dysfunction in men with benign prostatic hyperplasia: results from the Proscar long-term efficacy and safety study. J Urol 2005;173:903–7
   PubMed Web of Science ®Google Scholar
• Zakaria L, Anastasiadis AG, Shabsigh R. Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression. Int Urol Nephrol 2001;33:283–92
   Google Scholar
• Frankel SJ, Donovan JL, Peters TI, et al. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol 1988;51:677–85
   Google Scholar
• McVary KT, McKenna KE. The relationship between erectile dysfunction and lower urinary tract symptoms: epidemiological, clinical, and basic science evidence. Curr Urol Rep 2004;5:251–7
   PubMedGoogle Scholar
• McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 2006;97(Suppl 2):23–8
   PubMedGoogle Scholar
• Bloch W, Klotz T, Loch C, et al. Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide. Prostate 1997;3:1–8
   Google Scholar
• Felsen D, Dardashti K, Ostad M, et al. Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction. J Urol 2003;169:1569–72
   PubMed Web of Science ®Google Scholar
• Golomb E, Rosenzweig N, Eilam R, et al. Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats. J Androl 2000;21:58–64
   PubMed Web of Science ®Google Scholar
• Persson K, Pandita RK, Spitsbergen JM, et al. Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats. Am J Physiol 1998;275(4 Pt 2):R1366–73
   Google Scholar
• Behr-Roussel D, Chamiot-Clerc P, Bernabe J, et al. Erectile dysfunction in spontaneously hypertensive rats: pathophysiological mechanisms. Am J Physiol Regul Integr Comp Physiol 2003;284:R682–8
   PubMedGoogle Scholar
• Chang S, Hypolite JA, Zderic SA, et al. Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase. Am J Physiol Regul Integr Comp Physiol 2005;289:R1124–30
   PubMed Web of Science ®Google Scholar
• Bing W, Chang S, Hypolite JA, et al. Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase. Am J Physiol Renal Physiol 2003;285:F990–7
   PubMed Web of Science ®Google Scholar
• Azadzoi KM, Babayan RK, Kozlowski R, et al. Chronic ischemia increases prostatic smooth muscle contraction in the rabbit. J Urol 2003;170(2 Pt 1):659–63
   Google Scholar
• Azadzoi KM, Tarcan T, Siroky MB, et al. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit. J Urol 1999;161:1626–35
   PubMed Web of Science ®Google Scholar
• Kozlowski R, Kershen RT, Siroky MB, et al. Chronic ischemia alters prostate structure and reactivity in rabbits. J Urol 2001;165:1019–26
   PubMed Web of Science ®Google Scholar
• Wei JT, Calhoun EA, Jacobsen SJ. Benign Prostatic Hyperplasia. In: Litwin MS, Saigal CS, eds. Urologic Diseases in America. DHHS, PHS, NIH, NIDDK. Washington, DC: GPO, 2004; NIH Publication No. 04–5512:43–67
   Google Scholar
• Wei JT, Calhoun EA, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 2005;173:1256–61
   Google Scholar
• Verhamme KM, Dieleman JP, Bleumink GS, et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care – the Triumph project. Eur Urol 2002;42:323–8
   PubMed Web of Science ®Google Scholar
• McVary KT. Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur Urol 2005;47:838–45
   PubMed Web of Science ®Google Scholar
• McVary KT, Roehrborn CG, Kaminetsky JC, et al. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2007;177:1401–7
   PubMed Web of Science ®Google Scholar
• McVary KT, Monnig W, Camps JL Jr, et al. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 2007;177:1071–7
   PubMed Web of Science ®Google Scholar
• McVary KT, Rademaker A, Lloyd GL, et al. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2005;174(4 Pt 1):1327–433
   Google Scholar
• Birnbaum HG, Cremieux PY, Greenberg PE, et al. Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics 1999;16:1–8
   PubMed Web of Science ®Google Scholar